Maxzúd M K, Daniotti J L, Maccioni H J
Centro de Investigaciones en Química Biológica de Córdoba, CIQUIBIC (UNC-CONICET), Departamento de Química Biológica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
J Biol Chem. 1995 Aug 25;270(34):20207-14. doi: 10.1074/jbc.270.34.20207.
The synthesis of the oligosaccharide of gangliosides is carried out in the Golgi complex by successive sugar transfers to proper glycolipid acceptors. To examine how the product of one glycosylation step couples with the next transfer step, the endogenous gangliosides of Golgi membranes from 14-day-old chick embryo retina were labeled from CMP-[3H]NeuAc or UDP-[3H]GalNAc or UDP-[3H]Gal in conditions which do not allow vesicular intercompartmental transport. After saturation of the endogenous acceptor capacity, labeling was mostly in the immediate acceptors of the corresponding labeled sugars. However, some labeled intermediates progressed to more glycosylated gangliosides if the membranes were incubated in a second step in the presence of the necessary unlabeled sugar nucleotides. This was particularly evident in the case of membranes incubated with UDP-[3H]Gal, in which most of the [3H]Gal-labeled lactosylceramide synthesized in the first step was converted to GM3 and GD3, or to GM2 or to GD1a in a second incubation step in the presence of unlabeled CMP-NeuAc alone, or together with UDP-GalNAc, or together with UDP-Gal plus UDP-GalNAc, respectively. Conversion was time dependent and dilution-independent. Since prior reports using brefeldin A indicate that transfer steps catalyzed by GalNAc-T, Gal-T2, and Sial-T4 localize in the trans-Golgi network (TGN), our results lead to the following major conclusions: (a) transfer steps catalyzed by GalNAc-T, Gal-T2, and Sial-T4 colocalize and are functionally coupled in the TGN; (b) proximal Golgi Gal-T1, Sial-T1, and Sial-T2, and their corresponding glycolipid acceptors, extend their presence to the TGN, and (c), GalNAc-T and Sial-T2 compete for a common pool of acceptor GM3 in the synthesis of GM2 and GD3.
神经节苷脂寡糖的合成在高尔基体复合体中通过将糖依次转移至合适的糖脂受体来进行。为了研究一个糖基化步骤的产物如何与下一个转移步骤偶联,在不允许囊泡间运输的条件下,用CMP-[³H]NeuAc或UDP-[³H]GalNAc或UDP-[³H]Gal对14日龄鸡胚视网膜高尔基体膜的内源性神经节苷脂进行标记。在内源性受体容量饱和后,标记主要存在于相应标记糖的直接受体中。然而,如果在第二步中在存在必要的未标记糖核苷酸的情况下孵育膜,一些标记的中间体就会进展为糖基化程度更高的神经节苷脂。在用UDP-[³H]Gal孵育的膜的情况下尤其明显,其中在第一步中合成的大部分[³H]Gal标记的乳糖基神经酰胺在第二步单独存在未标记的CMP-NeuAc时,或与UDP-GalNAc一起,或与UDP-Gal加UDP-GalNAc一起孵育时,分别转化为GM3和GD3,或GM2或GD1a。转化是时间依赖性的且与稀释无关。由于先前使用布雷菲德菌素A的报告表明由GalNAc-T、Gal-T2和Sial-T4催化的转移步骤定位于反式高尔基体网络(TGN),我们的结果得出以下主要结论:(a) 由GalNAc-T、Gal-T2和Sial-T4催化的转移步骤共定位且在TGN中功能偶联;(b) 高尔基体近端的Gal-T1、Sial-T1和Sial-T2及其相应的糖脂受体延伸至TGN;以及(c) 在GM2和GD3的合成中,GalNAc-T和Sial-T2竞争共同的受体GM3池。